Search Results for "Abbott Dartford Murex Biotech Ltd"

21:02 EDT 24th August 2016 | BioPortfolio

Matching Channels

Urokinase Abbott

Biotech jobs

The Top 10 Medical Device Companies

Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in ...

Czech Republic

Able to take advantage of a €2 European funding stimulus in 2009, the Czech Republic is one of Europe's top 5 centers for biotechnology companies. In just over decade, the Czech Republic ha...

The Top 100 Drugs

The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the co...

Matching News

Beijing Strong Biotech Grants Technology License to Abbott

Beijing Strong Biotechnologies (BSBE) recently signed a technology license granting Abbott Labs rights to its clinical chemistry testing products, which BSBE currently manufactures in China. Initially...

Abbott enters systems integration deal with Diasend

A collaboration deal has been reached by Abbott and Diasend to allow a cloud-based connection between Abbott's LibreLink syst -More- 

Abbott deal for St. Jude spurs company split talk

When Abbott Laboratories said on Thursday it would buy heart device company St. Jude Medical Inc for $25 billion, it set off a flurry of Wall Street speculation over whether Abbott Chief Executive Mil...

Abbott to Present at Wells Fargo Healthcare Conference

ABBOTT PARK, Ill., Aug. 24, 2016 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the Wells Fargo 2016 Healthcare Conference on Wednesday, Sept. 7, 2016. Brian Yoor, senior vice president, fina...

Abbott Hosts Conference Call for First-Quarter Earnings

ABBOTT PARK, Ill., March 28, 2016 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its first-quarter 2016 financial results on Wednesday, April 20, 2016, before the market opens.  The anno...

Abbott to Present at Barclays Capital 2016 Global Healthcare Conference

ABBOTT PARK, Ill., March 14, 2016 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the Barclays Capital 2016 Global Healthcare Conference on Thursday, March 17, 2016. Brian Yoor, senior vice preside...

Abbott pays $24bn in cash and stock for St. Jude Medical

Abbott Laboratories Inc. agreed to pay $24.1bn for publicly traded St. Jude Medical Inc., whose shareholders will receive $46.75 in cash and 0.8708 Abbott common shares for each share held (worth $84....

Abbott Declares 370th Consecutive Quarterly Dividend

ABBOTT PARK, Ill., June 10, 2016 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 26 cents per share. This marks the 370th consecut...

Matching PubMed Articles

Neuro-oncology biotech industry progress report.

The Brain Tumor Biotech Center at the Feinstein Institute for Medical Research, in collaboration with Voices Against Brain Cancer hosted The Brain Tumor Biotech Summit at in New York City in June 2015...

Response to proposed research to reverse brain death: more than regulatory failure.

In early May 2016, reports of a bizarre study to attempt a reversal of brain death made the headlines, but there was not even a squeak from the authorities. The "Reanima Project" is a collaboration be...

Erratum: When biotech goes bad.

Second-quarter biotech job picture.

First-quarter biotech job picture.

Search Whole site using Google

Quick Search
Advertisement Advertisement